Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Breathlessness in advanced illness

Palliative and end-of-life care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Acute severe respiratory distress

Sudden breathlessness, stridor, haemoptysis, pleuritic pain, unilateral absent breath sounds, cyanosis, exhaustion, altered consciousness or haemodynamic instability may represent a reversible respiratory emergency.

Action: Use ABCDE assessment, sit the person upright when tolerated, provide calm continuous support and activate emergency help within the agreed treatment ceiling. Give oxygen for hypoxaemia, treat the suspected cause promptly and provide symptom relief in parallel; do not assume acute deterioration is terminal solely because illness is advanced.

Synopsis

Assess breathlessness as a subjective multidimensional symptom, treat reversible emergencies and disease mechanisms, combine non-pharmacological measures with proportionate opioid or oxygen trials, and document goal-concordant escalation before crisis.

  • Breathlessness is the patient's perception; respiratory rate, oxygen saturation and imaging help find mechanisms but do not measure distress completely.
  • First-line assessment defines onset, triggers, positional and exertional pattern, associated pain, cough, haemoptysis, wheeze, fever and current treatment ceiling.
  • Treat reversible causes when likely benefit matches goals: bronchodilator, antibiotic, diuretic, anticoagulation, drainage, transfusion, stent or radiotherapy may be appropriate.
  • First-line non-drug care is upright positioning, cool facial airflow, calm coaching, loosened clothing, pacing, breathing control and rapid access to a trusted contact.
  • A handheld fan directed across the central face can reduce breathlessness perception even when oxygen saturation is normal.
  • Give supplemental oxygen for documented or strongly suspected hypoxaemia; in non-hypoxaemic breathlessness, oxygen is not routinely better than air and should be a time-limited trial only when benefit is demonstrated.
  • Low-dose morphine can reduce refractory breathlessness after mechanism treatment and non-drug measures, with lower starting exposure in frailty and renal or hepatic caution.
  • Benzodiazepines are not first-line for breathlessness itself; reserve them for severe associated anxiety or panic after safer measures and monitor combined respiratory sedation.
  • The gold-standard plan records reversible causes, non-drug techniques, medicine and oxygen trials, rescue instructions, escalation ceiling and review of function and toxicity.

Key red flags

Stridor, facial or neck swelling, inability to speak, drooling or rapidly worsening upper-airway noise requires immediate airway and senior oncological assessment.

Sudden pleuritic pain, syncope, unilateral leg swelling or unexplained tachycardia suggests pulmonary embolism and needs goal-concordant urgent evaluation.

Acute unilateral chest pain with reduced breath sounds and instability suggests tension pneumothorax and requires emergency decompression assessment.

Fever, purulent sputum, shock or new focal chest signs may indicate infection requiring prompt antibiotics and sepsis care when consistent with goals.

Respiratory exhaustion, falling rate, confusion, cyanosis or rising carbon dioxide is more dangerous than visible tachypnoea alone.

Drowsiness and respiratory rate below 8 after opioid or sedative exposure suggests toxicity and requires airway support and proportionate reversal.

Major haemoptysis requires the catastrophic-bleed plan, presence and airway positioning rather than leaving the patient to fetch complex medicines.

Respiratory exhaustion

Falling effort, silent chest

Investigation priorities

01
First-line bedside respiratory assessmentFirst stepFirst line

Measure rate, effort, speech, arousal, oxygen saturation, pulse, pressure and temperature and examine airway, chest, heart, legs and fluid status.

Management branches

Acute deteriorationTreat emergency and distress together

Breathlessness has developed suddenly, intensified rapidly or is accompanied by instability or red flags.

  1. Use ABCDE, position and reassure, provide oxygen to the appropriate target when hypoxaemic and activate emergency support within known treatment limits.
  2. Treat the suspected mechanism promptly and obtain focused tests that can change antibiotics, diuresis, anticoagulation, drainage, airway treatment or ventilatory support.
  3. Give proportionate symptom relief, communicate uncertainty and document the current ceiling, location and next review rather than treating DNACPR as no treatment.

Key medicines

Immediate-release oral morphine for refractory breathlessnessIn an opioid-naive frail adult, a local palliative protocol may begin with 2 to 2.5 mg orally as needed or at a defined interval and titrate from response; verify the exact regimen, maximum and review timing and use a renal-appropriate alternative when morphine is unsuitable.Monitor arousability, respiratory rate and effort, hallucinations, myoclonus, nausea and constipation; renal impairment and concurrent sedatives raise toxicity risk.
Lorazepam for severe breathlessness-related anxietyWhen anxiety remains severe despite non-drug measures and other causes are addressed, use 500 micrograms orally or sublingually as a patient-specific as-needed dose under the local palliative protocol, with a clear minimum interval and review.Not first-line for breathlessness itself; opioids, alcohol, frailty, hypercapnia and hepatic impairment increase sedation, falls, delirium and respiratory risk.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG31 care of dying adultsIndividual breathlessness assessment, non-drug care, opioid, benzodiazepine and oxygen considerations.
  • NICE NG115 COPD recommendationsOxygen targets, pulmonary rehabilitation, inhaled treatment and advanced COPD care.
  • Scottish palliative breathlessness guidelineNon-pharmacological care, opioid and anxiolytic examples and oxygen principles.
  • GMC end-of-life treatment guidanceGoal-concordant treatment decisions, capacity and continuing symptom care.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
, altered consciousness or inability to speak after sustained distress signals impending ventilatory failure.